{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:06:57Z","timestamp":1692670017876},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[1990,6,1]],"date-time":"1990-06-01T00:00:00Z","timestamp":644198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovascular Drugs and Therapy"],"published-print":{"date-parts":[[1990,6]]},"DOI":"10.1007\/bf00357034","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T13:50:26Z","timestamp":1099403426000},"page":"579-584","source":"Crossref","is-referenced-by-count":2,"title":["Encainide versus flecainide in the treatment of chronic resistant paroxysmal atrial tachyarrhythmias"],"prefix":"10.1007","volume":"4","author":[{"given":"Philippe","family":"Coumel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1218","volume":"76","author":"JF Leclercq","year":"1983","unstructured":"Leclercq JF, Coumel P. La flecainide: Un nouvel antiarythmique. Arch Mal Couer 1983;76:1218?1230.","journal-title":"Arch Mal Couer"},{"key":"CR2","first-page":"237","volume":"35","author":"F Chouty","year":"1986","unstructured":"Chouty F, Leclerq JF, Coumel P. Interet de la flecainide dans les troubles du rythme supraventriculaire. Ann Cardiol Angeiol 1986;35:237?241.","journal-title":"Ann Cardiol Angeiol"},{"key":"CR3","first-page":"373","volume":"75","author":"P Coumel","year":"1982","unstructured":"Coumel P, Attuel P, Leclercq JF, Friocourt P. Arythmies auriculaires d'origine vagale ou catecholergique. Effects compares du traitement beta-bloqueur et phenomene d'echappement. Arch Mal Coeur 1982;75:373?388.","journal-title":"Arch Mal Coeur"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4613-2827-8_12","volume-title":"Tachycardias","author":"P Coumel","year":"1984","unstructured":"Coumel P. Atrial fibrillation. In: Surawicz B, Pratap Reddy C, Prystowsky EN, eds. Tachycardias. Boston: Martinus Nijhoff, 1984:231?244."},{"key":"CR5","first-page":"63","volume-title":"Reentrant arrhythmias","author":"MA Allessie","year":"1977","unstructured":"Allessie MA, Bonke FIM, Lammers WJEP, The effects of carbamylcholine, adrenaline, ouabain, quinidine, and verapamil on circus movement tachycardia in isolated segments of rabbit atrial myocardium. In: Kulbertus H, ed. Reentrant arrhythmias. Lancaster: MT Press. Lancaster: 1977:63."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0002-8703(84)90589-1","volume":"108","author":"P Coumel","year":"1984","unstructured":"Coumel P, Escoubet B, Attuel P. Beta-blocking therapy in atrial and ventricular tachyarrhythmias: Experience with nadolol. Am Heart J 1984;108:1098?1108.","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0735-1097(84)80146-1","volume":"4","author":"P Brugada","year":"1984","unstructured":"Brugada P, Abdollah H, Wellens HJJ, Suppession of incessant supraventricular tachycardia by intravenous and oral encainide. J Am Coll Cardiol 1984;4:1255?1260.","journal-title":"J Am Coll Cardiol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/hrt.53.2.164","volume":"53","author":"JE Creamer","year":"1985","unstructured":"Creamer JE, Nathan AW, Camm AJ. Successful treatment of atrial tachycardias with flecainide acetate. Br Heart J 1985;53:164?166.","journal-title":"Br Heart J"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0735-1097(86)80233-9","volume":"7","author":"KP Kunze","year":"1986","unstructured":"Kunze KP, Kuck KH, Schluter M, Bliefeld W. Effect of encainide on chronic ectopic atrial tachycardia. J Am Coll Cardiol 1986;7:1121?1126.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00357034.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00357034\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00357034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T01:02:04Z","timestamp":1554771724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00357034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,6]]},"references-count":9,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[1990,6]]}},"alternative-id":["BF00357034"],"URL":"https:\/\/doi.org\/10.1007\/bf00357034","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,6]]}}}